Objective: To investigate whether quinolones produce in vivo responses comp
arable to reported ill vitro activity against the spectrum of organisms in
uncomplicated urinary tract infection (UTI) in Nigeria.
Design: Equal numbers of patients with urine culture positive UTI were rand
omised to oral quinolone, perfloxacin 400 mg bd twice a day and ofloxacin 2
00 mg bd twice a day for five days,
Setting: Out-patient clinics and wards at the University College Hospital,
Ibadan,
Subjects: Sixty patients aged sixteen years and above with uncomplicated UT
I,
Main outcome measures: Number of isolates, number of patients with clinical
and bacteriological cure one week after commencing therapy. Relative effec
tiveness and side effects of the drugs.
Results: Sixty four bacterial isolates were obtained with the enterobacteri
aceae comprising 86%. Sixty two (97%) were sensitive to both drugs in vitro
. Clinical cure occurred in 57 patients (95%), being 28 (93%) in those taki
ng perfloxacin and 29 (97%) in those taking ofloxacin, Barteriological cure
occurred in 55 patients (92%), being 27 (90%) in those taking perfloxacin
and 28 (93%) in those taking ofloxacin, Fifty nine of the 64 isolates (92%)
were eliminated in one week, 30 of 33 (91%) in those taking perfloxacin, a
nd 29 of 31 (94%) in those taking ofloxacin; the difference was insignifica
nt (p=1.16), The enterobacteriaceae were generally susceptible to both drug
s. Side effects were minor and infrequent.
Conclusion: Quinolones were highly active against the common urinary pathog
ens in these Nigerian patients and can be reliably employed in treatment wh
en culture results are unavailable.